spacer

CDC HomeHIV/AIDS > Topics > Testing

space HIV Testing
space
arrow Trends
space
arrow Challenges
space
arrow CDC Response
space
arrow Rapid HIV Testing
space
arrow Healthcare Settings
space
arrow Non-Health-care Settings
space
arrow Questions & Answers
space
arrow Fact Sheets
space
arrow Slide Sets
space
arrow Podcasts
space
arrow Reports
space
arrow Recommendations & Guidelines
space
arrow Bibliography
space
arrow Links
space
arrow Other Documents
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Challenges
spacer
spacer

Our current medical systems have supported the concept of HIV/AIDS as an “exceptional” disease, one which requires special considerations even before people can receive an HIV test. This exceptionalism, in turn, tends to breed stigma by singling out those who are tested for HIV.

One result of the current process is that many people infected with HIV are not tested until they are already sick. This is because risk factor assessment has determined who gets tested but, unfortunately, fails to identify many people who are infected. Indeed, the thesis on which CDC's revised Recommendations is based is that HIV/AIDS is not exceptional, but rather, a treatable disease that meets the criteria for routine screening, e.g.,

  • It is a serious health disorder that can be diagnosed before symptoms develop.
  • It can be detected by reliable, inexpensive screening tests.
  • Infected patients have years of life to gain if treatment is initiated early; and the costs of screening are reasonable in relation to the benefits (analyses show that routine testing for HIV is as cost-effective as screening for hypertension, colon cancer, and breast cancer).

Some of the challenges resulting from this exceptionalism, as well as other barriers to testing and care include:

  • Declines in HIV incidence observed in the early 1990s have leveled and might even have reversed in certain populations in recent years.
  • Although the introduction of highly active antiretroviral therapy has improve survival rates, progress in effecting earlier diagnosis has been improved only modestly: the proportion of people who first tested positive for HIV <1 year before receiving a diagnosis of AIDS was 39% in 2004 (19).
  • Despite advances in HIV prevention and care, a substantial number of opportunities for HIV prevention are missed. Indeed, routine screening is rarely performed in health care settings in the United States.
  • At publicly funded sites, approximately 70% of persons tested received their results and information regarding the test, but fewer persons likely received HIV prevention counseling and referrals. In private settings, a lower proportion of all clients are tested, and few receive prevention counseling and referrals (20-23).
  • Delays in receiving testing results have resulted in barriers to learning one's HIV status. Rapid tests provide opportunities to dramatically increase the number of people who learn their HIV test results (24-25).
spacer
Last Modified: October 30, 2006
Last Reviewed: October 30, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
horizontal dividing line
Contact Us
Please click here to view contact information.
divider
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 8A-8P (EST) M-F. Closed weekends and major federal holidays - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services